# [World Report] Bundibugyo vaccine trial begins

Source: [thelancet.com](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02239-7/fulltext?rss=yes) · 2026-11-07 · Medicine
Page: https://themorning.science/story/world-report-bundibugyo-vaccine-trial-begins-07a1245954e964f7
Kind: research · Impact: medium

## In brief

- A vaccine trial, named Tumaini, has begun in DR Congo to test vaccines against Bundibugyo virus infection.
- Bundibugyo virus infection has reportedly killed more than 5000 people in DR Congo.
- The Lancet World Report by Talha Burki covers the trial launch.

## Why it matters

Bundibugyo virus has no licensed vaccine, so the trial's results could inform how outbreaks of this filovirus are controlled in affected regions.

## Timeline

- 2026-11-07: The Lancet World Report on the Tumaini trial beginning published

## Coverage

- [[World Report] Bundibugyo vaccine trial begins](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)02239-7/fulltext?rss=yes) — thelancet.com, 2026-11-07

Tags: vaccines, bundibugyo virus, ebola-like outbreaks, clinical trials, dr congo, public health

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science